Pharma pledges help on patient access to chronic-disease meds

Drugmakers are pledging to help revamp drug distribution and grapple with other obstacles to patient access to medicines in developing countries, the Financial Times reports. Prices aren't the issue, companies say, but rather infrastructure. Report

Suggested Articles

A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Zantac and some OTC antacids.

Roche is steamrolling with Ocrevus, and to maintain that lead, its touting long-term data that show the earlier it’s given, the better patients do.

New data shows a significant reduction in relapse rates in patients taking Novartis' repurposed cancer drug ofatumumab.